Biotechnology; Clinical Trials; Life Science
EnteroBiotix has raised €42M across 3 funding rounds from 7 investors, most recently a round in May 2026. Based in Edinburgh, UK; founded 2017; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-04 | Other | €22M | Existing investors,Scottish National Investment Bank,Thairm Bio | View deal → |
| 2021-09-07 | Series A | €18M | Kineticos Ventures,Scottish Enterprise,SIS Ventures,Thairm Bio | View deal → |
| 2019-04-01 | Seed | €2.3M | Equity Gap | View deal → |
